Our results showing, a continuum between CNM and CMTDIB phenotypes in zebrafish, similarly to the human conditions, confirm this animal model to be a powerful tool to investigate mutations of DNM2 in vivo. The gene discussed is DNM2; the disease is Charcot-Marie-Tooth disease dominant intermediate B.